Factors affecting hospital length of stay following pelvic exenteration surgery

Total pelvic exenteration are performed in patients with locally advanced or recurrent pelvic malignances. Many patients have prolong hospital length of stay (LOS), but risk factors are not clearly identified.

[1]  L. Masya,et al.  Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  S. Małgorzewicz,et al.  The impact of nutritional status and appetite on the hospital length of stay and postoperative complications in elderly patients with severe aortic stenosis before aortic valve replacement , 2016, Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery.

[3]  J. Carmichael,et al.  Surgical site infection impact of pelvic exenteration procedure , 2015, Journal of surgical oncology.

[4]  M. Kusters,et al.  Survival after pelvic exenteration for T4 rectal cancer , 2015, The British journal of surgery.

[5]  C. Koh,et al.  Clinical algorithms for the diagnosis and management of urological leaks following pelvic exenteration. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  Jane M. Young,et al.  Preoperative Body Mass Index, 30-Day Postoperative Morbidity, Length of Stay and Quality of Life in Patients Undergoing Pelvic Exenteration Surgery for Recurrent and Locally-Advanced Rectal Cancer , 2014, Annals of coloproctology.

[7]  B. Fellman,et al.  Pelvic exenteration: impact of age on surgical and oncologic outcomes. , 2014, Gynecologic oncology.

[8]  R. Turley,et al.  Pelvic Exenteration for the Treatment of Locally Advanced Colorectal and Bladder Malignancies in the Modern Era , 2014, Journal of Gastrointestinal Surgery.

[9]  B. Fellman,et al.  The effect of body mass index on surgical outcomes and survival following pelvic exenteration. , 2012, Gynecologic oncology.

[10]  J. Young,et al.  Urological leaks after pelvic exenterations comparing formation of colonic and ileal conduits. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  Paula Ravasco,et al.  Definition and classification of cancer cachexia: an international consensus. , 2011, The Lancet. Oncology.

[12]  I. de Wever.  Pelvic Exenteration: Surgical Aspects and Analysis of Early and Late Morbidity in a Series of 106 Patients , 2011, Acta chirurgica Belgica.

[13]  P. Alberius,et al.  Pelvic Exenteration for Advanced and Recurrent Malignancy , 2010, World Journal of Surgery.

[14]  U. Neumann,et al.  Long‐term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies , 2010, Journal of surgical oncology.

[15]  M. Pine,et al.  Patient characteristics and the occurrence of never events. , 2010, Archives of surgery.

[16]  A. Gadducci,et al.  Treatment options in recurrent cervical cancer (Review). , 2010, Oncology letters.

[17]  F. Landoni,et al.  Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. , 2009, Gynecologic oncology.

[18]  A. Eggermont,et al.  Total Pelvic Exenteration for Primary and Recurrent Malignancies , 2009, World Journal of Surgery.

[19]  D. Moorman,et al.  Impact of Body Mass Index on Perioperative Outcomes in Patients Undergoing Major Intra-abdominal Cancer Surgery , 2008, Annals of Surgical Oncology.

[20]  J. Alcázar,et al.  Primary Vaginal Reconstruction at the Time of Pelvic Exenteration for Gynecologic Cancer: Morbidity Revisited , 2008, Annals of Surgical Oncology.

[21]  C. Wood,et al.  Pelvic Exenteration Affords Safe and Durable Treatment for Locally Advanced Rectal Carcinoma , 2007, Annals of Surgical Oncology.

[22]  S. Kehoe.  Treatments for gynaecological cancers. , 2006, Best practice & research. Clinical obstetrics & gynaecology.

[23]  M. Höckel,et al.  Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. , 2006, The Lancet. Oncology.

[24]  T. Pawlik,et al.  Pelvic Exenteration for Advanced Pelvic Malignancies , 2006, Annals of Surgical Oncology.

[25]  N. Hacker,et al.  Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. , 2005, Gynecologic oncology.

[26]  Marvin J. López,et al.  Evolution of pelvic exenteration. , 2005, Surgical oncology clinics of North America.

[27]  K. Odunsi,et al.  Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute , 2004, International Journal of Gynecologic Cancer.

[28]  N. Petrelli,et al.  Pelvic exenteration and its modifications. , 1996, American journal of surgery.